Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT01266460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma, Not Otherwise Specified
Recurrent Cervical Carcinoma

Interventions

BIOLOGICAL: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
OTHER: Laboratory Biomarker Analysis

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]
[object Object]